nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A7—Fluorouracil—colon cancer	0.324	0.37	CbGbCtD
Cefotaxime—SLC22A11—Methotrexate—colon cancer	0.188	0.214	CbGbCtD
Cefotaxime—SLC22A7—Methotrexate—colon cancer	0.179	0.204	CbGbCtD
Cefotaxime—SLC22A8—Methotrexate—colon cancer	0.109	0.125	CbGbCtD
Cefotaxime—SLC22A6—Methotrexate—colon cancer	0.076	0.0868	CbGbCtD
Cefotaxime—Superinfection—Fluorouracil—colon cancer	0.00908	0.0758	CcSEcCtD
Cefotaxime—Superinfection—Capecitabine—colon cancer	0.00634	0.053	CcSEcCtD
Cefotaxime—Local reaction—Fluorouracil—colon cancer	0.00372	0.0311	CcSEcCtD
Cefotaxime—Encephalopathy—Fluorouracil—colon cancer	0.00321	0.0268	CcSEcCtD
Cefotaxime—Tenderness—Fluorouracil—colon cancer	0.00236	0.0197	CcSEcCtD
Cefotaxime—Encephalopathy—Capecitabine—colon cancer	0.00224	0.0187	CcSEcCtD
Cefotaxime—Colitis—Irinotecan—colon cancer	0.00207	0.0173	CcSEcCtD
Cefotaxime—Encephalopathy—Methotrexate—colon cancer	0.00167	0.0139	CcSEcCtD
Cefotaxime—Renal impairment—Irinotecan—colon cancer	0.00164	0.0137	CcSEcCtD
Cefotaxime—Dermatitis bullous—Fluorouracil—colon cancer	0.00157	0.0131	CcSEcCtD
Cefotaxime—Colitis—Capecitabine—colon cancer	0.00138	0.0115	CcSEcCtD
Cefotaxime—Candida infection—Capecitabine—colon cancer	0.00137	0.0115	CcSEcCtD
Cefotaxime—Neutropenia—Vincristine—colon cancer	0.0013	0.0108	CcSEcCtD
Cefotaxime—Eosinophilia—Fluorouracil—colon cancer	0.00128	0.0107	CcSEcCtD
Cefotaxime—Neutropenia—Irinotecan—colon cancer	0.00126	0.0105	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Capecitabine—colon cancer	0.0012	0.00999	CcSEcCtD
Cefotaxime—Renal failure—Irinotecan—colon cancer	0.00118	0.00988	CcSEcCtD
Cefotaxime—Jaundice—Irinotecan—colon cancer	0.00117	0.0098	CcSEcCtD
Cefotaxime—Haemolytic anaemia—Capecitabine—colon cancer	0.00116	0.00967	CcSEcCtD
Cefotaxime—Renal impairment—Capecitabine—colon cancer	0.0011	0.00917	CcSEcCtD
Cefotaxime—Dermatitis bullous—Capecitabine—colon cancer	0.00109	0.00914	CcSEcCtD
Cefotaxime—Haemoglobin—Irinotecan—colon cancer	0.00109	0.00907	CcSEcCtD
Cefotaxime—Haemorrhage—Irinotecan—colon cancer	0.00108	0.00902	CcSEcCtD
Cefotaxime—Agranulocytosis—Fluorouracil—colon cancer	0.00108	0.00899	CcSEcCtD
Cefotaxime—Vaginal inflammation—Methotrexate—colon cancer	0.00107	0.00895	CcSEcCtD
Cefotaxime—Haemoglobin—Fluorouracil—colon cancer	0.00104	0.00869	CcSEcCtD
Cefotaxime—Haemorrhage—Fluorouracil—colon cancer	0.00103	0.00864	CcSEcCtD
Cefotaxime—Vaginal infection—Methotrexate—colon cancer	0.00101	0.00845	CcSEcCtD
Cefotaxime—Aplastic anaemia—Methotrexate—colon cancer	0.00101	0.00841	CcSEcCtD
Cefotaxime—Arrhythmia—Irinotecan—colon cancer	0.000965	0.00806	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000941	0.00786	CcSEcCtD
Cefotaxime—Arrhythmia—Fluorouracil—colon cancer	0.000925	0.00772	CcSEcCtD
Cefotaxime—Bronchospasm—Capecitabine—colon cancer	0.000889	0.00742	CcSEcCtD
Cefotaxime—Ill-defined disorder—Irinotecan—colon cancer	0.000873	0.00729	CcSEcCtD
Cefotaxime—Leukopenia—Vincristine—colon cancer	0.000865	0.00722	CcSEcCtD
Cefotaxime—Malaise—Irinotecan—colon cancer	0.000848	0.00708	CcSEcCtD
Cefotaxime—Neutropenia—Capecitabine—colon cancer	0.000845	0.00706	CcSEcCtD
Cefotaxime—Leukopenia—Irinotecan—colon cancer	0.000842	0.00703	CcSEcCtD
Cefotaxime—Convulsion—Vincristine—colon cancer	0.000837	0.00699	CcSEcCtD
Cefotaxime—Leukopenia—Fluorouracil—colon cancer	0.000806	0.00674	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000799	0.00667	CcSEcCtD
Cefotaxime—Renal failure—Capecitabine—colon cancer	0.000792	0.00661	CcSEcCtD
Cefotaxime—Discomfort—Irinotecan—colon cancer	0.000791	0.00661	CcSEcCtD
Cefotaxime—Anaphylactic shock—Vincristine—colon cancer	0.000788	0.00658	CcSEcCtD
Cefotaxime—Jaundice—Capecitabine—colon cancer	0.000785	0.00656	CcSEcCtD
Cefotaxime—Convulsion—Fluorouracil—colon cancer	0.000781	0.00652	CcSEcCtD
Cefotaxime—Thrombocytopenia—Vincristine—colon cancer	0.000772	0.00645	CcSEcCtD
Cefotaxime—Anaphylactic shock—Irinotecan—colon cancer	0.000768	0.00641	CcSEcCtD
Cefotaxime—Discomfort—Fluorouracil—colon cancer	0.000758	0.00633	CcSEcCtD
Cefotaxime—Shock—Irinotecan—colon cancer	0.000755	0.00631	CcSEcCtD
Cefotaxime—Agranulocytosis—Capecitabine—colon cancer	0.000752	0.00628	CcSEcCtD
Cefotaxime—Thrombocytopenia—Irinotecan—colon cancer	0.000752	0.00628	CcSEcCtD
Cefotaxime—Anaphylactic shock—Fluorouracil—colon cancer	0.000735	0.00614	CcSEcCtD
Cefotaxime—Haemoglobin—Capecitabine—colon cancer	0.000727	0.00607	CcSEcCtD
Cefotaxime—Hepatitis—Capecitabine—colon cancer	0.000723	0.00604	CcSEcCtD
Cefotaxime—Haemorrhage—Capecitabine—colon cancer	0.000723	0.00604	CcSEcCtD
Cefotaxime—Thrombocytopenia—Fluorouracil—colon cancer	0.00072	0.00601	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000701	0.00585	CcSEcCtD
Cefotaxime—Erythema multiforme—Capecitabine—colon cancer	0.000684	0.00571	CcSEcCtD
Cefotaxime—Pain—Vincristine—colon cancer	0.000674	0.00563	CcSEcCtD
Cefotaxime—Eosinophilia—Methotrexate—colon cancer	0.000666	0.00556	CcSEcCtD
Cefotaxime—Pain—Irinotecan—colon cancer	0.000657	0.00548	CcSEcCtD
Cefotaxime—Arrhythmia—Capecitabine—colon cancer	0.000646	0.0054	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Vincristine—colon cancer	0.000645	0.00538	CcSEcCtD
Cefotaxime—Feeling abnormal—Irinotecan—colon cancer	0.000633	0.00528	CcSEcCtD
Cefotaxime—Neutropenia—Methotrexate—colon cancer	0.000629	0.00525	CcSEcCtD
Cefotaxime—Pain—Fluorouracil—colon cancer	0.000629	0.00525	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Irinotecan—colon cancer	0.000628	0.00524	CcSEcCtD
Cefotaxime—Abdominal pain—Vincristine—colon cancer	0.000623	0.0052	CcSEcCtD
Cefotaxime—Body temperature increased—Vincristine—colon cancer	0.000623	0.0052	CcSEcCtD
Cefotaxime—Body temperature increased—Irinotecan—colon cancer	0.000607	0.00507	CcSEcCtD
Cefotaxime—Abdominal pain—Irinotecan—colon cancer	0.000607	0.00507	CcSEcCtD
Cefotaxime—Feeling abnormal—Fluorouracil—colon cancer	0.000606	0.00506	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000595	0.00497	CcSEcCtD
Cefotaxime—Renal failure—Methotrexate—colon cancer	0.00059	0.00492	CcSEcCtD
Cefotaxime—Ill-defined disorder—Capecitabine—colon cancer	0.000584	0.00488	CcSEcCtD
Cefotaxime—Urticaria—Fluorouracil—colon cancer	0.000584	0.00488	CcSEcCtD
Cefotaxime—Body temperature increased—Fluorouracil—colon cancer	0.000581	0.00485	CcSEcCtD
Cefotaxime—Hypersensitivity—Vincristine—colon cancer	0.000581	0.00485	CcSEcCtD
Cefotaxime—Malaise—Capecitabine—colon cancer	0.000568	0.00474	CcSEcCtD
Cefotaxime—Hypersensitivity—Irinotecan—colon cancer	0.000566	0.00472	CcSEcCtD
Cefotaxime—Leukopenia—Capecitabine—colon cancer	0.000564	0.00471	CcSEcCtD
Cefotaxime—Agranulocytosis—Methotrexate—colon cancer	0.00056	0.00467	CcSEcCtD
Cefotaxime—Hypersensitivity—Fluorouracil—colon cancer	0.000542	0.00452	CcSEcCtD
Cefotaxime—Haemoglobin—Methotrexate—colon cancer	0.000541	0.00452	CcSEcCtD
Cefotaxime—Diarrhoea—Vincristine—colon cancer	0.000539	0.0045	CcSEcCtD
Cefotaxime—Haemorrhage—Methotrexate—colon cancer	0.000538	0.0045	CcSEcCtD
Cefotaxime—Hepatitis—Methotrexate—colon cancer	0.000538	0.0045	CcSEcCtD
Cefotaxime—Discomfort—Capecitabine—colon cancer	0.00053	0.00442	CcSEcCtD
Cefotaxime—Diarrhoea—Irinotecan—colon cancer	0.000525	0.00439	CcSEcCtD
Cefotaxime—Pruritus—Fluorouracil—colon cancer	0.00052	0.00434	CcSEcCtD
Cefotaxime—Erythema multiforme—Methotrexate—colon cancer	0.000509	0.00425	CcSEcCtD
Cefotaxime—Shock—Capecitabine—colon cancer	0.000506	0.00422	CcSEcCtD
Cefotaxime—Diarrhoea—Fluorouracil—colon cancer	0.000503	0.0042	CcSEcCtD
Cefotaxime—Thrombocytopenia—Capecitabine—colon cancer	0.000503	0.0042	CcSEcCtD
Cefotaxime—Vomiting—Vincristine—colon cancer	0.000501	0.00419	CcSEcCtD
Cefotaxime—Rash—Vincristine—colon cancer	0.000497	0.00415	CcSEcCtD
Cefotaxime—Dermatitis—Vincristine—colon cancer	0.000497	0.00415	CcSEcCtD
Cefotaxime—Headache—Vincristine—colon cancer	0.000494	0.00412	CcSEcCtD
Cefotaxime—Vomiting—Irinotecan—colon cancer	0.000488	0.00408	CcSEcCtD
Cefotaxime—Rash—Irinotecan—colon cancer	0.000484	0.00404	CcSEcCtD
Cefotaxime—Dermatitis—Irinotecan—colon cancer	0.000484	0.00404	CcSEcCtD
Cefotaxime—Headache—Irinotecan—colon cancer	0.000481	0.00402	CcSEcCtD
Cefotaxime—Nausea—Vincristine—colon cancer	0.000468	0.00391	CcSEcCtD
Cefotaxime—SLC22A11—renal system—colon cancer	0.000468	0.102	CbGeAlD
Cefotaxime—Vomiting—Fluorouracil—colon cancer	0.000468	0.0039	CcSEcCtD
Cefotaxime—Rash—Fluorouracil—colon cancer	0.000464	0.00387	CcSEcCtD
Cefotaxime—Dermatitis—Fluorouracil—colon cancer	0.000463	0.00387	CcSEcCtD
Cefotaxime—Headache—Fluorouracil—colon cancer	0.000461	0.00385	CcSEcCtD
Cefotaxime—SLC22A7—renal system—colon cancer	0.000457	0.0999	CbGeAlD
Cefotaxime—Nausea—Irinotecan—colon cancer	0.000456	0.00381	CcSEcCtD
Cefotaxime—Pain—Capecitabine—colon cancer	0.000439	0.00367	CcSEcCtD
Cefotaxime—Nausea—Fluorouracil—colon cancer	0.000437	0.00365	CcSEcCtD
Cefotaxime—Ill-defined disorder—Methotrexate—colon cancer	0.000435	0.00363	CcSEcCtD
Cefotaxime—Feeling abnormal—Capecitabine—colon cancer	0.000423	0.00354	CcSEcCtD
Cefotaxime—Malaise—Methotrexate—colon cancer	0.000423	0.00353	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Capecitabine—colon cancer	0.00042	0.00351	CcSEcCtD
Cefotaxime—Leukopenia—Methotrexate—colon cancer	0.00042	0.0035	CcSEcCtD
Cefotaxime—Urticaria—Capecitabine—colon cancer	0.000408	0.00341	CcSEcCtD
Cefotaxime—Abdominal pain—Capecitabine—colon cancer	0.000406	0.00339	CcSEcCtD
Cefotaxime—Body temperature increased—Capecitabine—colon cancer	0.000406	0.00339	CcSEcCtD
Cefotaxime—Convulsion—Methotrexate—colon cancer	0.000406	0.00339	CcSEcCtD
Cefotaxime—SLC15A1—epithelium—colon cancer	0.000396	0.0866	CbGeAlD
Cefotaxime—Discomfort—Methotrexate—colon cancer	0.000394	0.00329	CcSEcCtD
Cefotaxime—SLC22A11—digestive system—colon cancer	0.000384	0.084	CbGeAlD
Cefotaxime—Anaphylactic shock—Methotrexate—colon cancer	0.000383	0.00319	CcSEcCtD
Cefotaxime—Hypersensitivity—Capecitabine—colon cancer	0.000379	0.00316	CcSEcCtD
Cefotaxime—SLC22A7—digestive system—colon cancer	0.000375	0.082	CbGeAlD
Cefotaxime—Thrombocytopenia—Methotrexate—colon cancer	0.000375	0.00313	CcSEcCtD
Cefotaxime—SLC15A1—renal system—colon cancer	0.000367	0.0803	CbGeAlD
Cefotaxime—Pruritus—Capecitabine—colon cancer	0.000364	0.00304	CcSEcCtD
Cefotaxime—Diarrhoea—Capecitabine—colon cancer	0.000352	0.00294	CcSEcCtD
Cefotaxime—Pain—Methotrexate—colon cancer	0.000327	0.00273	CcSEcCtD
Cefotaxime—Vomiting—Capecitabine—colon cancer	0.000327	0.00273	CcSEcCtD
Cefotaxime—Rash—Capecitabine—colon cancer	0.000324	0.00271	CcSEcCtD
Cefotaxime—Dermatitis—Capecitabine—colon cancer	0.000324	0.0027	CcSEcCtD
Cefotaxime—Headache—Capecitabine—colon cancer	0.000322	0.00269	CcSEcCtD
Cefotaxime—Feeling abnormal—Methotrexate—colon cancer	0.000315	0.00263	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Methotrexate—colon cancer	0.000313	0.00261	CcSEcCtD
Cefotaxime—Nausea—Capecitabine—colon cancer	0.000305	0.00255	CcSEcCtD
Cefotaxime—Urticaria—Methotrexate—colon cancer	0.000304	0.00254	CcSEcCtD
Cefotaxime—Body temperature increased—Methotrexate—colon cancer	0.000302	0.00253	CcSEcCtD
Cefotaxime—Abdominal pain—Methotrexate—colon cancer	0.000302	0.00253	CcSEcCtD
Cefotaxime—SLC15A1—digestive system—colon cancer	0.000301	0.0659	CbGeAlD
Cefotaxime—SLC22A11—liver—colon cancer	0.000286	0.0626	CbGeAlD
Cefotaxime—Hypersensitivity—Methotrexate—colon cancer	0.000282	0.00235	CcSEcCtD
Cefotaxime—SLC22A7—liver—colon cancer	0.000279	0.0611	CbGeAlD
Cefotaxime—Pruritus—Methotrexate—colon cancer	0.000271	0.00226	CcSEcCtD
Cefotaxime—SLC15A1—vagina—colon cancer	0.000266	0.0582	CbGeAlD
Cefotaxime—SLC22A8—renal system—colon cancer	0.000264	0.0578	CbGeAlD
Cefotaxime—Diarrhoea—Methotrexate—colon cancer	0.000262	0.00219	CcSEcCtD
Cefotaxime—Vomiting—Methotrexate—colon cancer	0.000243	0.00203	CcSEcCtD
Cefotaxime—Rash—Methotrexate—colon cancer	0.000241	0.00201	CcSEcCtD
Cefotaxime—Dermatitis—Methotrexate—colon cancer	0.000241	0.00201	CcSEcCtD
Cefotaxime—Headache—Methotrexate—colon cancer	0.00024	0.002	CcSEcCtD
Cefotaxime—SLC15A2—renal system—colon cancer	0.00023	0.0502	CbGeAlD
Cefotaxime—Nausea—Methotrexate—colon cancer	0.000227	0.0019	CcSEcCtD
Cefotaxime—SLC15A1—liver—colon cancer	0.000224	0.0491	CbGeAlD
Cefotaxime—SLC15A2—vagina—colon cancer	0.000166	0.0364	CbGeAlD
Cefotaxime—SLC15A2—lymph node—colon cancer	0.000108	0.0235	CbGeAlD
